Prohibition of Insider Trading

DR. LAL PATHLABS LIMITED

General information about company

Scrip Code		539524
NSE Symbol		LALPATHLAB
MSEI Symbol		NOTLISTED
Name of the Signatory		VINAY GUJRAL
Designation of Signatory		Company Secretary and Compliance Officer
Place		GURUGRAM
Date of Filing		18-05-2026
ISIN Code		INE600L01024
Disclosure under Regulation		Regulation 7 (2)
Revised Filing		No

PIT Disclosure

Sr. No.	Type of instrument	Category of person	Name of the person	CIN / DIN	Securities held prior to acquisition / disposal		Securities acquired / disposed			Securities held post acquisition / disposal		Date of allotment advice / acquisition of shares / sale of shares specify		Mode of acquisition / disposal	Date of intimation to company	Buy		Sell		Exchange on which the trade was executed	Notes
					No. of security	% of shareholding	No. of security	Value of security (in Rs.)	Transaction type	No. of security	% of shareholding	From date	To date			Notional value	No. of units (contracts × lot size)	Notional value	No. of units (contracts × lot size)
					No. of security	% of shareholding	No. of security	Value of security (in Rs.)	Transaction type	No. of security	% of shareholding	From date	To date			Notional value	No. of units (contracts × lot size)	Notional value	No. of units (contracts × lot size)
1	Equity	Other	Dr. Lal PathLabs Employee Welfare Trust		652222	0.39%	1976	9,880.00	Sell	650246	0.39%	14-05-2026	15-05-2026	ESOP	18-05-2026					NA	Textual Information(1)
2	Equity	Director	Rahul Sharma	00956625	2500	0.00%	2500	4,081,146.00	Sell	0	0.00%	15-05-2026	15-05-2026	Market Sale	18-05-2026					NSE

Text Block

Textual Information(1)

It may be kindly noted that shares were transferred at Effective Exercise price (Post Bonus Issue- 2025) of INR 5/- per share under Company’s ESOP plan and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).